|
THUMPD3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.258570E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.836900E-03 |
| Normal-vs-Stage2 |
5.343900E-02 |
| Normal-vs-Stage3 |
4.849000E-04 |
| Normal-vs-Stage4 |
1.341720E-03 |
| Stage1-vs-Stage2 |
7.247000E-01 |
| Stage1-vs-Stage3 |
2.456600E-01 |
| Stage1-vs-Stage4 |
3.145200E-01 |
| Stage2-vs-Stage3 |
2.480200E-01 |
| Stage2-vs-Stage4 |
3.014600E-01 |
| Stage3-vs-Stage4 |
9.353600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.177500E-04 |
| Normal-vs-AfricanAmerican |
6.443600E-01 |
| Normal-vs-Asian |
1.146040E-02 |
| Caucasian-vs-AfricanAmerican |
5.748300E-02 |
| Caucasian-vs-Asian |
7.758600E-01 |
| AfricanAmerican-vs-Asian |
1.343800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.496000E-03 |
| Normal-vs-Female |
1.800350E-03 |
| Male-vs-Female |
9.636200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.003640E-02 |
| Normal-vs-Age(41-60Yrs) |
8.575900E-04 |
| Normal-vs-Age(61-80Yrs) |
1.549890E-02 |
| Normal-vs-Age(81-100Yrs) |
1.550030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.690800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.776800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.539400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.375200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.174400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.927600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.699170E-01 |
| Classical-VS-Follicular |
1.064610E-01 |
| Classical-VS-Other |
1.875610E-01 |
| Classical-VS-Normal |
1.471740E-02 |
| Tall-VS-Follicular |
7.826200E-01 |
| Tall-VS-Other |
5.354400E-01 |
| Tall-VS-Normal |
6.341800E-03 |
| Follicular-VS-Other |
5.146800E-01 |
| Follicular-VS-Normal |
3.897200E-03 |
| Other-VS-Normal |
4.423800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.243100E-03 |
| Normal-vs-N1 |
4.234300E-04 |
| N0-vs-N1 |
1.668350E-01 |
|
|
